Posted on July 01st, 2020
Most people, when they receive a diagnosis of colorectal cancer are left with no idea what their financial situation would be. According to the American Institute of Cancer Research (AICR), each passing year, cancer is going to cost more money than any other disease.
Colorectal cancer is the third most common cancer in the US, and about 9% and 8% of new cases occur in men and women respectively. Thus, colorectal cancer care greatly contributes to the total expenditure of $125 billion on cancer care each year in the US. In the year 2016, the total healthcare costs for the treatment of colorectal cancer amounted to $124,425. The average monthly costs for first-line treatment of metastatic colorectal cancer reach $12,345 and the average lifetime monthly costs for systemic treatment amount to $7,883.
The total costs for colorectal cancer are mainly attributed to the early-stage treatment, which includes monitoring, surveillance, and surgery as well as the terminal-stage treatment that requires hospitalization, chemotherapy, and supportive care. However, each patient's cost to treat colorectal cancer may be different. The costs involved in colorectal cancer care and management vary and depend on factors such as:
The major healthcare costs to be considered in the management of colorectal cancer include:
The costs of diagnostic laboratory tests for colorectal cancer are high because multiple tests will be needed to confirm a diagnosis of colorectal cancer as misdiagnosis is common in asbestos-related cancers. Once the diagnosis of colorectal cancer is established, the treatment plan will be worked out, and here are the average costs of different treatment techniques:
Apart from this, hospitalization costs could reach up to $37,369 and visits to specialist doctors would sum up to $34,582, which includes the administration of chemotherapy.
Colorectal cancer care can be divided into three phases, and the costs per month include:
Additional costs of colorectal cancer vary from $20,000 to $50,000. These are secondary expenses and are costs related to the treatment including: